TungHsuan Yang - Taiyen Biotech Director Office

All Insiders . Taiwan . 
Stock . Taiyen Biotech Co . Stakeholders . Insider . TungHsuan Yang
1737 Stock  TWD 32.15  0.20  0.62%   

Insider

TungHsuan Yang is Director Office of Taiyen Biotech Co
Phone886 6 2160 688
Webhttps://www.tybio.com.tw

Taiyen Biotech Management Efficiency

The company has return on total asset (ROA) of 0.0346 % which means that it generated a profit of $0.0346 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0642 %, meaning that it generated $0.0642 on every $100 dollars invested by stockholders. Taiyen Biotech's management efficiency ratios could be used to measure how well Taiyen Biotech manages its routine affairs as well as how well it operates its assets and liabilities.
Taiyen Biotech Co has accumulated 53.08 M in total debt with debt to equity ratio (D/E) of 2.0, which is about average as compared to similar companies. Taiyen Biotech has a current ratio of 5.3, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Taiyen Biotech until it has trouble settling it off, either with new capital or with free cash flow. So, Taiyen Biotech's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Taiyen Biotech sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Taiyen to invest in growth at high rates of return. When we think about Taiyen Biotech's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

ChiaMing ChaiUni President Enterprises Corp
N/A
FangHao HanGreat Wall Enterprise
N/A
YunYun YehStandard Foods Corp
N/A
ChaoKai HwangUni President Enterprises Corp
N/A
ShenLong PengTaiwan Fertilizer Co
N/A
HuiMing FongStandard Foods Corp
N/A
Joseph MiauLien Hwa Industrial
N/A
Chien LiangGreat Wall Enterprise
N/A
Jin JanGreat Wall Enterprise
N/A
ChingTyan LeeUni President Enterprises Corp
N/A
Thomas HuangStandard Foods Corp
N/A
Chris YenLien Hwa Industrial
N/A
FuJung LaiUni President Enterprises Corp
N/A
Jessie ChenLien Hwa Industrial
N/A
Yeong HuangTaiwan Fertilizer Co
N/A
Jimmy ChenStandard Foods Corp
N/A
Chyuan SungTaiwan Fertilizer Co
N/A
TsangHsien HsuTaiwan Fertilizer Co
N/A
ChinSheng LinTaiwan Fertilizer Co
N/A
Roger LinLien Hwa Industrial
N/A
TsungYi LiuUni President Enterprises Corp
56
Taiyen Biotech Co., Ltd. provides various health and beauty products under the TAIYEN brand Hong Kong, Taiwan, Mainland China, and Macau. The company was founded in 1952 and is based in Tainan, Taiwan. TAIYEN BIOTECH is traded on Taiwan Stock Exchange in Taiwan. Taiyen Biotech Co (1737) is traded on Taiwan Stock Exchange in Taiwan and employs 33 people.

Management Performance

Return On Equity0.0642
Return On Asset0.0346

Taiyen Biotech Leadership Team

Elected by the shareholders, the Taiyen Biotech's board of directors comprises two types of representatives: Taiyen Biotech inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Taiyen. The board's role is to monitor Taiyen Biotech's management team and ensure that shareholders' interests are well served. Taiyen Biotech's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Taiyen Biotech's outside directors are responsible for providing unbiased perspectives on the board's policies.
Wei Su, Director Department
MeiYu Chuang, Chief Auditor
MeiWen Chen, Director Department
TungHsuan Yang, Director Office
ShiHui Chen, President
ChiehHan Lee, VP Department

Taiyen Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Taiyen Biotech a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity0.0642
Return On Asset0.0346
Profit Margin0.11 %
Operating Margin0.12 %
Current Valuation4.82 B
Shares Outstanding200 M
Shares Owned By Insiders48.28 %
Shares Owned By Institutions5.34 %
Price To Earning14.76 X
Price To Book1.00 X

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
ESRTEmpire State Realty
CCitigroup
CCitigroup

Additional Tools for Taiyen Stock Analysis

When running Taiyen Biotech's price analysis, check to measure Taiyen Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Taiyen Biotech is operating at the current time. Most of Taiyen Biotech's value examination focuses on studying past and present price action to predict the probability of Taiyen Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Taiyen Biotech's price. Additionally, you may evaluate how the addition of Taiyen Biotech to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY